


Aims to achieve an attractive level of income combined with capital growth.
| Name | % Net Assets | 
|---|---|
| British American Tobacco | 4.6% | 
| HSBC | 3.9% | 
| Royal Dutch Shell 'B' | 3.9% | 
| Centrica | 3.6% | 
| AstraZeneca | 3.6% | 
| GlaxoSmithKline | 3.6% | 
| BP | 3.5% | 
| Vodafone | 3.4% | 
| Aviva | 3.1% | 
| National Grid | 3.0% | 
| Key | % Net Assets | 
|---|---|
| 4.6% | |
| 3.9% | |
| 3.9% | |
| 3.6% | |
| 84% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 1,606.66p | 
| Currency | GBP | 
| Change | 7.73p | 
| % | 0.48% | 
| YTD change | 94.11p | 
| YTD % | 6.22% | 
| Fund Inception | 07/04/2006 | 
|---|---|
| Fund Manager | Pan European Equities Team | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | £100 | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research